Michael Buhle
Vermogen: - $ op 31-05-2026
Vermogen: - $ op 31-05-2026
Michael Buhle is President & Chief Executive Officer at Aspira Women's Health, Inc. since 2025.
Formerly, Mr. Buhle was Chief Commercial Officer at Biovision Diagnostics LLC from 2022 to 2024 and Vice President-Sales & Americas at Congenica Ltd. Mr. Buhle completed undergraduate studies at the University of Clarke.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 20-04-2026 | 0 ( -.--% ) | - $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| ASPIRA WOMEN'S HEALTH INC. | Algemeen Directeur | 21-02-2025 |
| Bedrijven | Functie | Einde |
|---|---|---|
Biovision Diagnostics LLC
Biovision Diagnostics LLC Medical/Nursing ServicesHealth Services Provides laboratory services | Corporate Officer/Principal | 01-12-2024 |
Congenica Ltd.
Congenica Ltd. Packaged SoftwareTechnology Services Operates as a digital health company that enables analysis of genomic data | Corporate Officer/Principal | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 4 |
|---|---|
Aspira Women's Health, Inc.
Aspira Women's Health, Inc. BiotechnologyHealth Technology Develops and manufactures diagnostic test kits | Health Technology |
University of Clarke
University of Clarke Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Congenica Ltd.
Congenica Ltd. Packaged SoftwareTechnology Services Operates as a digital health company that enables analysis of genomic data | Technology Services |
Biovision Diagnostics LLC
Biovision Diagnostics LLC Medical/Nursing ServicesHealth Services Provides laboratory services | Health Services |
Kies jouw editie
Alle financiële informatie op nationaal niveau